The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...

The syringes are said to be produced using a hands-free and fully automated process to minimise contamination risks.

BD will invest $35M to expand its Nebraska syringe plant, adding 50 jobs and boosting U.S. supply of essential medical ...

BD (NYSE: BDX) announced today that it plans to invest more than $35 million in U.S.-based prefilled flush syringe ...

BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...

As a result, the agency said it had issued a trio of warning letters on March 18— including one to the China-based syringe maker Jiangsu Shenli Medical Production Co. Ltd.—as well as to the U ...

BD (Becton, Dickinson and Company) (NYSE: BDX), and ten23 health, announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology. The collaboration aims to ...

Pune, Maharashtra, India, March 30 2021 (Wiredrelease) MarketDesk –:The latest statistical surveying research study on Global Disposable Sterile Insulin Syringe Market 2021 by Manufacturers, Type and ...

Access to sterile syringes is a key to giving people with substance-use disorders a chance to stay as safe as possible as they work toward recovery, she says.